Integrating a methylation‐based liquid biopsy into early liver cancer diagnostic pathways: Clinical insights from a trial
Clinical and Translational Discovery · 2026-06 · 6 (3)
DOI: 10.1002/ctd2.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Discovery, online erschienen am 18.06.2026. Verfasst von Jie Zhao und 3 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhao, J., Gu, S., Wu, Z., & Han, X. (2026). Integrating a methylation‐based liquid biopsy into early liver cancer diagnostic pathways: Clinical insights from a trial. Clinical and Translational Discovery, 6(3). https://doi.org/10.1002/ctd2.70167
Vancouver
Zhao J, Gu S, Wu Z, Han X. Integrating a methylation‐based liquid biopsy into early liver cancer diagnostic pathways: Clinical insights from a trial. Clinical and Translational Discovery. 2026;6(3). doi:10.1002/ctd2.70167
BibTeX
@article{Zhao2026,
author = {Zhao, Jie and Gu, Shuangzhen and Wu, Zhen and Han, Xiaoliang},
title = {Integrating a methylation‐based liquid biopsy into early liver cancer diagnostic pathways: Clinical insights from a trial},
journal = {Clinical and Translational Discovery},
year = {2026},
volume = {6},
number = {3},
doi = {10.1002/ctd2.70167}
}
EUVIMED